CD BioSciences Announces Cytoskeleton-Targeted Tumor Marker Development Service for Cancer Diagnosis
CD BioSciences has announced its cytoskeleton-based tumor marker development service for cancer diagnosis. NEW YORK, UNITED STATES, April 26, 2024 /EINPresswire.com/ -- CD BioSciences, a comprehensive biotech company, has recently unveiled its …